Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic

Leukemia

Volumn 24, Issue 2, 2010, Pages 425-428

  Stary, J ^a   Jabali, Y ^b   Trka, J ^a   Hrusak, O ^a   Gajdos, P ^a   Hrstkova, H ^c,d   Sterba, J ^c,d   Blazek, B ^e   Hak, J ^f   Prochazkova, D ^g   Cerna, Z ^a   Smisek, P ^a   Sedlacek, P ^a   Vavra, V ^a   Mihal, V ^h   Hrodek, O ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Regional Hospital   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e Teaching Hospital   (Czech Republic)

^f UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^g Masaryk   (Czech Republic)

^h PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BREAKPOINT CLUSTER REGION PROTEIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; MIXED LINEAGE LEUKEMIA PROTEIN; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CZECH REPUBLIC; DRUG MEGADOSE; EVENT FREE SURVIVAL; FLOW CYTOMETRY; GENE REARRANGEMENT; GENETIC SCREENING; HUMAN; IMMUNOPHENOTYPING; LETTER; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 76749136697     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.255     Document Type: Letter

References (4)

1. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthra-cyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL Study Group. Blood 2000; 95: 3310-3322.
2. Stary J, Gajdos P, Hrstkova H, Blazek B, Slavik Z, Mihal V et al. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology. Med Pediatr Oncol 2002; 39: 125-127.
3. Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, et al. German-Austrian-Swiss ALL Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patiens enrolled in the trial ALL-BFM 95. Blood 2008; 111: 4477-4489.
4. Conter V, Valsecchi MG, Silvestri D, Campbell M, Dibar E, Magyarosy E et al. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. Lancet 2007; 369: 123-131.